This week in evidence

Latest evidence

Newly indexed published studies in this library.

2022Evidence: Moderate

Testosterone replacement therapy and cardiovascular disease.

International journal of impotence research

Contemporary evidence does not support the historical concern that testosterone replacement therapy broadly increases cardiovascular risk in appropriately selected men; benefits and risks depend on indication, formulation, monitoring, and baseline cardiovascular status.

International journal of impotence research2022PMID 34999717

Testosterone replacement therapy and cardiovascular disease.

Contemporary evidence does not support the historical concern that testosterone replacement therapy broadly increases cardiovascular risk in appropriately selected men; benefits and risks depend on indication, formulation, monitoring, and baseline cardiovascular status.

ReviewEvidence: ModerateRelevance: HighRouzier commentary
Testosterone & Cardiovascular Risk
OpenPublished November 2022Strength Moderate · Relevance High